Analysis of Cell Saver use and mortality in liver transplant
Introduction: Liver transplantation is considered the best treatment for irreversible liver disease. Due to the complexity of the procedure generally multiple blood transfusions are required. One option to reduce this need is the use of Cell Saver providing blood cell recovery and reinfusion. Purpos...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Associação Brasileira de Transplante de Órgãos
2017-06-01
|
| Series: | Brazilian Journal of Transplantation |
| Subjects: | |
| Online Access: | https://bjt.emnuvens.com.br/revista/article/view/86 |
| _version_ | 1811224526204174336 |
|---|---|
| author | André Ibrahim David Catiana Mitica Gritti André Gustavo Santos Pereira Tiago Emanuel de Souza Felipe Sbrolini Borges Angela Caputi Arnaldo Bernal Gilberto Peron Jorge Marcelo Padilla Mancero |
| author_facet | André Ibrahim David Catiana Mitica Gritti André Gustavo Santos Pereira Tiago Emanuel de Souza Felipe Sbrolini Borges Angela Caputi Arnaldo Bernal Gilberto Peron Jorge Marcelo Padilla Mancero |
| author_sort | André Ibrahim David |
| collection | DOAJ |
| description | Introduction: Liver transplantation is considered the best treatment for irreversible liver disease. Due to the complexity of the procedure generally multiple blood transfusions are required. One option to reduce this need is the use of Cell Saver providing blood cell recovery and reinfusion. Purpose: to evaluate mortality in the number of washed red blood cell units recovered by Cell Saver and perioperative mortality. Methods: Data collection of transplant patients using CellSaver on the period from July 2014 to February 2017. Results: Performed 56 liver transplants, the diagnosis prevalent was liver cirrhosis by hepatitis C virus (37,5%). Of these 45 (80,4%) of the transplants used Cell Saver, which had a median MELD of 24,5 (range 7-50). Taking into account the use of Cell Saver in washed red blood cell units and recovered notes a median of four (range 1-45). 12 died (26,7%), the average of these MELD was 25,5 (range 1-50) and the use of washed red blood cell and recovered was a median of 4,5. Conclusion: Patients who died used a similar amount of washed and recovered erythrocyte units.
|
| first_indexed | 2024-04-12T08:50:31Z |
| format | Article |
| id | doaj.art-4c729601a9ab43d7a9f579289573400d |
| institution | Directory Open Access Journal |
| issn | 2764-1589 |
| language | English |
| last_indexed | 2024-04-12T08:50:31Z |
| publishDate | 2017-06-01 |
| publisher | Associação Brasileira de Transplante de Órgãos |
| record_format | Article |
| series | Brazilian Journal of Transplantation |
| spelling | doaj.art-4c729601a9ab43d7a9f579289573400d2022-12-22T03:39:36ZengAssociação Brasileira de Transplante de ÓrgãosBrazilian Journal of Transplantation2764-15892017-06-0120310.53855/bjt.v20i3.86Analysis of Cell Saver use and mortality in liver transplantAndré Ibrahim David0Catiana Mitica Gritti1André Gustavo Santos Pereira2Tiago Emanuel de Souza3Felipe Sbrolini Borges4Angela Caputi5Arnaldo Bernal6Gilberto Peron7Jorge Marcelo Padilla Mancero8Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Hospital Beneficência Portuguesa - Unidade de Transplante Renal – São Paulo/SP – Brasil.Introduction: Liver transplantation is considered the best treatment for irreversible liver disease. Due to the complexity of the procedure generally multiple blood transfusions are required. One option to reduce this need is the use of Cell Saver providing blood cell recovery and reinfusion. Purpose: to evaluate mortality in the number of washed red blood cell units recovered by Cell Saver and perioperative mortality. Methods: Data collection of transplant patients using CellSaver on the period from July 2014 to February 2017. Results: Performed 56 liver transplants, the diagnosis prevalent was liver cirrhosis by hepatitis C virus (37,5%). Of these 45 (80,4%) of the transplants used Cell Saver, which had a median MELD of 24,5 (range 7-50). Taking into account the use of Cell Saver in washed red blood cell units and recovered notes a median of four (range 1-45). 12 died (26,7%), the average of these MELD was 25,5 (range 1-50) and the use of washed red blood cell and recovered was a median of 4,5. Conclusion: Patients who died used a similar amount of washed and recovered erythrocyte units. https://bjt.emnuvens.com.br/revista/article/view/86TransplantLiverTransfusionInfusionCell Saver |
| spellingShingle | André Ibrahim David Catiana Mitica Gritti André Gustavo Santos Pereira Tiago Emanuel de Souza Felipe Sbrolini Borges Angela Caputi Arnaldo Bernal Gilberto Peron Jorge Marcelo Padilla Mancero Analysis of Cell Saver use and mortality in liver transplant Brazilian Journal of Transplantation Transplant Liver Transfusion Infusion Cell Saver |
| title | Analysis of Cell Saver use and mortality in liver transplant |
| title_full | Analysis of Cell Saver use and mortality in liver transplant |
| title_fullStr | Analysis of Cell Saver use and mortality in liver transplant |
| title_full_unstemmed | Analysis of Cell Saver use and mortality in liver transplant |
| title_short | Analysis of Cell Saver use and mortality in liver transplant |
| title_sort | analysis of cell saver use and mortality in liver transplant |
| topic | Transplant Liver Transfusion Infusion Cell Saver |
| url | https://bjt.emnuvens.com.br/revista/article/view/86 |
| work_keys_str_mv | AT andreibrahimdavid analysisofcellsaveruseandmortalityinlivertransplant AT catianamiticagritti analysisofcellsaveruseandmortalityinlivertransplant AT andregustavosantospereira analysisofcellsaveruseandmortalityinlivertransplant AT tiagoemanueldesouza analysisofcellsaveruseandmortalityinlivertransplant AT felipesbroliniborges analysisofcellsaveruseandmortalityinlivertransplant AT angelacaputi analysisofcellsaveruseandmortalityinlivertransplant AT arnaldobernal analysisofcellsaveruseandmortalityinlivertransplant AT gilbertoperon analysisofcellsaveruseandmortalityinlivertransplant AT jorgemarcelopadillamancero analysisofcellsaveruseandmortalityinlivertransplant |